TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC. – Trademark Portfolio

Entity Type: 03

TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 22 (Cordage) across 4 Nice Classification classes. The owner is based in Quebec.

5750 Royalmount Avenue

Town of Mont-Royal

Quebec H4P 1K5 , CA

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

22
Cordage (1 filing)

Ropes, string, nets, tents, awnings, tarpaulins, sails, sacks and bags

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC. have?

TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC. has 1 U.S. trademark filed with the USPTO.

What trademark classes does TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC. file in?

TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 22 (Cordage), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 25 covers clothing, footwear, headgear.

What is TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC.'s trademark registration success rate?

TEXTILES ABSORB-PLUS INC./ABSORB-PLUS TEXTILES INC. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.